EP4051713 - IMMUNOMODULATORY ANTI-CD73 ANTIBODIES AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.08.2022 Database last updated on 13.11.2024 | |
Former | The international publication has been made Status updated on 10.05.2021 | Most recent event Tooltip | 09.11.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states Corvus Pharmaceuticals, Inc. 863 Mitten Road Suite 102 Burlingame, CA 94010 / US | [2022/36] | Inventor(s) | 01 /
HOTSON, Andrew 863 Mitten Road, Suite 102 Burlingame, CA 94010 / US | 02 /
WILLINGHAM, Stephen 863 Mitten Road, Suite 102 Burlingame, CA 94010 / US | 03 /
MILLER, Richard, A. 863 Mitten Road, Suite 102 Burlingame, CA 94010 / US | [2022/36] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2022/36] | Application number, filing date | 20882718.8 | 02.11.2020 | [2022/36] | WO2020US58555 | Priority number, date | US201962929650P | 01.11.2019 Original published format: US 201962929650 P | US202063014015P | 22.04.2020 Original published format: US 202063014015 P | US202063078792P | 15.09.2020 Original published format: US 202063078792 P | [2022/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021087463 | Date: | 06.05.2021 | Language: | EN | [2021/18] | Type: | A1 Application with search report | No.: | EP4051713 | Date: | 07.09.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.05.2021 takes the place of the publication of the European patent application. | [2022/36] | Search report(s) | International search report - published on: | US | 06.05.2021 | (Supplementary) European search report - dispatched on: | EP | 03.04.2024 | Classification | IPC: | C07K16/28, A61P31/00, C07K16/40 | [2024/06] | CPC: |
C07K16/2896 (EP,KR,US);
A61K39/395 (EP);
A61P31/00 (EP);
A61P31/14 (KR,US);
A61P35/00 (KR);
C07K16/40 (EP);
G01N33/56983 (KR);
A61K2039/505 (EP,KR);
A61K39/00 (US);
C07K2317/21 (EP);
C07K2317/24 (EP);
C07K2317/52 (EP);
C07K2317/524 (EP);
C07K2317/55 (KR);
C07K2317/56 (EP);
C07K2317/565 (EP);
C07K2317/70 (EP,KR);
C07K2317/71 (EP,KR);
C07K2317/76 (EP,KR,US);
C07K2317/92 (KR,US);
G01N2333/165 (KR);
Y02A50/30 (EP)
(-)
| C-Set: |
A61K39/395, A61K2300/00 (EP)
|
Former IPC [2022/36] | C07K16/28, A61P31/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/36] | Title | German: | IMMUNMODULATORISCHE ANTI-CD73-ANTIKÖRPER UND DEREN VERWENDUNGEN | [2022/36] | English: | IMMUNOMODULATORY ANTI-CD73 ANTIBODIES AND USES THEREOF | [2022/36] | French: | ANTICORPS ANTI-CD73 IMMUNOMODULATEURS ET LEURS UTILISATIONS | [2022/36] | Entry into regional phase | 31.05.2022 | National basic fee paid | 31.05.2022 | Search fee paid | 31.05.2022 | Designation fee(s) paid | 31.05.2022 | Examination fee paid | Examination procedure | 31.05.2022 | Examination requested [2022/36] | 12.12.2022 | Amendment by applicant (claims and/or description) | 08.11.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | Fees paid | Renewal fee | 31.05.2022 | Renewal fee patent year 03 | 15.11.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2017100670 (CORVUS PHARMACEUTICALS INC [US], et al); | [X]WO2018187512 (CORVUS PHARMACEUTICALS INC [US]); | [E]WO2022037531 (AKESO BIOPHARMA INC [CN]); | International search | [Y]US2013123345 (DAVIS IAN C [US]); | [XY]US2019077873 (GRIFFIN EMILY PICCIONE [US], et al); |